STABILUS SE/ DE000STAB1L8 /
5/30/2024 8:56:02 AM | Chg. +0.30 | Volume | Bid8:56:02 AM | Ask8:56:02 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
57.80EUR | +0.52% | - Turnover: - |
57.80Bid Size: - | 58.20Ask Size: - | 1.44 bill.EUR | 3.01% | 14.10 |
GlobeNewswire
8:35 AM
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
8:30 AM
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
8:30 AM
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
8:30 AM
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
8:30 AM
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
GlobeNewswire
7:30 AM
Azerion announces expansion of its Executive Committee and new responsibilities